Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated filings document the formal disclosures of a NYSE-listed ingredient solutions company with common stock registered under the ticker INGR. Its 8-K reports include operating results, financial-condition updates, dividend-related corporate actions, leadership changes, board appointments and governance matters.
The company's proxy materials cover director elections, executive compensation, board structure, shareholder voting items and non-management director compensation. Other filings describe capital-structure details for its common stock, exit or disposal activities, impairment charges, restructuring matters and risk disclosures connected to manufacturing operations and the company's plant-based ingredient portfolio.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president David Eric Seip reported an award of 358.654 phantom stock units on March 6, 2026, designated as a grant under a Non-Qualified Deferred Compensation Plan. Each phantom stock unit represents the right to receive one share of Ingredion common stock.
Following this grant, Seip holds a total of 12,979.3271 phantom stock units directly. The units are valued for plan purposes using the closing price of Ingredion common stock of $114.83 per share on March 6, 2026.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president Michael J. Leonard received a grant of 718.333 phantom stock units on March 6, 2026 under the company’s Non-Qualified Deferred Compensation Plan. Each phantom unit represents the right to receive one share of common stock, bringing his total phantom stock holdings to 1,347.972 units.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president David Eric Seip received a grant of 11.186 shares of phantom stock valued at $117.46 per unit under a Non-Qualified Deferred Compensation Plan. Each phantom stock unit represents the right to receive one share of common stock, bringing his total phantom stock holdings to 12,620.6731 units.
Ingredion Inc senior vice president Michael J. Leonard reported an acquisition of phantom stock units through a grant under the company’s Non-Qualified Deferred Compensation Plan. He received 13.942 phantom stock units on the basis of a $117.46 closing share price, bringing his total phantom stock holdings to 629.639 units, each representing the right to receive one share of common stock.
Ingredion Inc reported that President and CEO James P. Zallie acquired 28,829 shares of common stock on a grant/award basis, valued at $117.94 per share. These are restricted stock units issued under the company’s stock incentive plan.
The RSUs may be settled only in common stock on a one-for-one basis and are scheduled to vest on February 25, 2029. They vest on a pro-rata basis if employment ends due to death, disability, or retirement, and in the case of retirement on or after February 25, 2027, they continue vesting under the original schedule.
Wolfe Nancy reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president and Chief HR Officer Nancy Wolfe received a grant of 3,053 restricted stock units tied to the company’s common stock, valued at $117.94 per share on the grant date. These RSUs vest on February 25, 2029, with pro-rata vesting in certain termination scenarios.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president David Eric Seip received an equity grant of 2,883 restricted stock units under the company’s stock incentive plan. Each RSU represents one share of common stock at a reference price of $117.94 per share and will vest on February 25, 2029, subject to continued service.
The award includes protections for certain employment endings. If employment ends because of death, disability, or retirement (as defined in the grant agreement), a pro-rata portion of the RSUs will vest. If retirement occurs on or after February 25, 2027, the RSUs continue to follow the original vesting schedule. Following this grant, Seip directly holds 30,734.396 common shares.
Ritchie Robert A. reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc executive Robert A. Ritchie received a grant of 4,749 restricted stock units (RSUs) of common stock. The RSUs were awarded at a reference price of $117.94 per share and increase his directly owned common stock (including RSUs) to 25,388.5858 shares after the grant.
The RSUs can be settled only in shares of Ingredion common stock on a one-for-one basis and are scheduled to vest on February 25, 2029. If his employment ends because of death, disability, or retirement (as defined in the grant agreement), the award vests on a pro‑rata basis. In the case of retirement on or after February 25, 2027, the RSUs continue to vest according to the original vesting schedule.
O'Riordan Michael reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president Michael O'Riordan received an equity grant in the form of 2,375 restricted stock units, treated as common stock, at a reference price of $117.94 per share. Following this award, his directly owned common stock equivalent holdings total 12,443.471 shares.
The RSUs were issued under the Ingredion Incorporated Stock Incentive Plan and vest on February 25, 2029. They may be settled only in shares of common stock on a one-for-one basis. If employment ends due to death, disability, or retirement, vesting occurs on a pro-rata basis, and for retirement on or after February 25, 2027, vesting continues according to the original schedule.
Kalotis Patrick Ilias reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc EVP Patrick Ilias Kalotis reported receiving an equity award linked to 3,053 shares of common stock. The award consists of restricted stock units granted at a reference value of $117.94 per unit and is held as direct ownership.
The RSUs may be settled only in common stock on a one-for-one basis and are scheduled to vest on February 25, 2029. Vesting can occur on a pro-rata basis upon death, disability, or retirement, and if retirement occurs on or after February 25, 2027, the units continue vesting under the original schedule.